Respiratory Update by LucidQuest Episode 6

Breaking Lung & Respiratory Health Updates: COPD Biologics, Breath Tests, Asthma Trials & More! 🫁🔬

Get the latest breakthroughs transforming lung and respiratory medicine—all in under 5 minutes. This week’s update covers critical developments across COPD, cystic fibrosis, asthma, COVID-19 prevention, and rare lung disease treatments:

💉 GSK’s Nucala One Step Closer to COPD Approval in Europe – EMA accepts GSK’s application following strong Phase 3 data; Nucala could become the first monthly-dosed biologic for COPD.
🫁 CF Foundation Backs Non-Invasive Breath Test for Pseudomonas – A $2.3M investment in Owlstone Medical supports the development of a child-friendly diagnostic alternative to invasive sputum sampling.
💊 Ensitrelvir Submitted in Japan as First Oral COVID-19 Post-Exposure Option – Shionogi files sNDA after Scorpio-PEP trial hits primary endpoint for COVID-19 prevention.
🔬 Glasmacinal Advances to New COPD Study – EpiEndo launches a second human challenge study in Germany to refine dosing and gather mechanistic biomarker data for its oral therapeutic.
🧬 UK Reviews Xolair Biosimilar AVT23 – Alvotech, Kashiv, and Advanz aim to improve access to anti-IgE therapies with their biosimilar submission to the MHRA.
🌟 Savara Files BLA for Molbreevi in aPAP – With a 2026 launch targeted, Savara seeks Priority Review for its inhaled therapy backed by Phase 3 lung function improvement data.
🧪 Biocad Begins Phase I Asthma Trial with BCD-272 – A new monoclonal antibody targeting airway inflammation enters early-stage testing for severe asthma patients.

📢 Stay Ahead in Lung & Respiratory Health Research!
✅ Like, share, and subscribe for weekly updates on Lung & Respiratory Health research
✅ Visit www.lqventures.com for expert healthcare insights and consulting services
✅ Contact LucidQuest at info@lqventures.com for strategic guidance on respiratory innovations and clinical research
🔔 Turn on notifications so you never miss an update!

#COPD #CysticFibrosis #COVID19 #AsthmaTreatment #Biologics #BreathTest #ClinicalTrials #XolairBiosimilar #aPAP #Molbreevi #LungHealth #RespiratoryResearch #LucidQuest #HealthcareInnovation #PharmaNews

Видео Respiratory Update by LucidQuest Episode 6 канала LucidQuest